Recombinant UPF0319 protein VP1009 (VP1009)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant UPF0319 Protein VP1009 (VP1009)

Recombinant UPF0319 protein VP1009 (VP1009) is a protein variant derived from the UPF0319 family, which is often associated with proteins of unknown function. The recombinant form of this protein is engineered for expression and purification in various host systems, such as bacteria (e.g., Escherichia coli), yeast, insect cells, and mammalian cells. This versatility allows researchers to optimize the protein's production based on specific requirements, including yield, post-translational modifications, and biological activity.

Expression and Purification of Recombinant UPF0319 Protein VP1009

The expression of recombinant UPF0319 protein VP1009 can be achieved through several host systems, each offering distinct advantages:

Table: Host Systems for Recombinant UPF0319 Protein VP1009 Expression

Host SystemAdvantagesDisadvantages
E. coliHigh yield, cost-effective, rapid productionLimited post-translational modifications
YeastSimilar to E. coli, with some additional modificationsMay not fully replicate mammalian modifications
Insect Cells with BaculovirusProvides complex post-translational modificationsMore expensive and complex setup
Mammalian CellsOffers comprehensive post-translational modificationsHigh cost, complex to work with

Future Directions

Future research on recombinant UPF0319 protein VP1009 should focus on elucidating its biological functions and exploring potential therapeutic or biotechnological applications. This may involve structural studies to understand its interactions with other cellular components and functional assays to determine its role in cellular processes.

References:

  1. Lifeome. UPF0319 protein VP10 - Lifeome. [Accessed 2025]

  2. Lifeome. UPF0319 protein VPA1 - Lifeome. [Accessed 2025]

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on purchasing method and location. Contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a guideline for your reference.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms maintain stability for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. To request a specific tag type, please inform us, and we will prioritize its implementation.
Synonyms
VP1009; UPF0319 protein VP1009
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
22-217
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Species
Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633)
Target Names
VP1009
Target Protein Sequence
DTTHKTDVS VTLSTAQGVQ VLFVNGVSTD ELSTPYTLID GSNQVVIKVN KAIGRGDKRT QVYSAPYILG FSSGAGELYI DAPSFRDKRQ ADKLFEKDTM DWKVSINDKS IDYSQYKMPG KKGAFPYSNL DEQLAEYNEL NGVYFSNGKR VELSELQATG TAKETHRVNS PLTKAKIAYL EMTDEERQLF MKWVSQQ
Uniprot No.

Q&A

What is UPF0319 protein VP1 and what expression systems are recommended for its production?

UPF0319 protein belongs to a family of uncharacterized proteins with potential functional significance in cellular processes. For recombinant expression of UPF0319 protein VP1, multiple host systems can be utilized, with E. coli and yeast offering the highest yields and most efficient production timelines. These prokaryotic and lower eukaryotic systems are particularly advantageous when large quantities of protein are required for structural or preliminary functional studies .
For applications requiring post-translational modifications, insect cells with baculovirus expression systems or mammalian cell expression platforms are recommended, as these systems can provide the necessary cellular machinery for correct protein folding and functional activity retention . The choice between expression systems should be guided by the specific research requirements, including protein purity needs, functional activity requirements, and experimental timeline constraints.

How do expression yields compare across different host systems for UPF0319 protein VP1?

Expression yields of recombinant UPF0319 protein VP1 vary significantly across host systems:

Expression SystemRelative YieldTurnaround TimePost-translational ModificationsActivity Retention
E. coliHighShort (2-5 days)MinimalVariable
YeastHighMedium (5-7 days)ModerateGood
Insect cellsMediumLong (10-14 days)SubstantialVery good
Mammalian cellsLowVery long (14-21 days)ComprehensiveExcellent
This comparative data demonstrates the inherent trade-off between production efficiency and biological authenticity of the expressed protein. The selection of an expression system should be guided by the specific requirements of your experimental design and research objectives .

What are the key differences between UPF0319 protein and the better-characterized Upf1p protein?

While both proteins share "UPF" in their nomenclature, they represent distinct protein families with different functions and characteristics. UPF0319 is an uncharacterized protein family (hence the UPF designation), whereas Upf1p is a well-characterized 971-amino acid protein essential for nonsense-mediated mRNA decay (NMD) .
Upf1p specifically interacts with nuclear pore proteins Nup100p and Nup116p, facilitating its association with newly synthesized mRNA as it is transported from the nucleus to the cytoplasm . This interaction is crucial for the NMD pathway that degrades mRNAs containing premature termination codons. In contrast, the specific functional interactions and physiological roles of UPF0319 proteins are still being elucidated, making them an active area of investigation in current research.

What optimization strategies are recommended for improving UPF0319 protein VP1 expression in E. coli systems?

When optimizing UPF0319 protein VP1 expression in E. coli, researchers should consider implementing the following evidence-based strategies:

  • Codon optimization: Adjust the coding sequence to reflect E. coli codon usage preferences, which can significantly enhance translation efficiency.

  • Expression vector selection: Test multiple vector systems with different promoters (T7, tac, etc.) to identify optimal transcriptional control for your specific protein construct.

  • Host strain selection: Compare expression levels in specialized strains such as BL21(DE3), Rosetta, or SHuffle, which are engineered to address specific protein expression challenges.

  • Induction conditions optimization: Systematically vary IPTG concentration (0.1-1.0 mM), induction temperature (16-37°C), and induction duration (4-24 hours) to identify conditions that maximize soluble protein yield.

  • Culture media formulation: Compare standard LB with enriched media such as TB or auto-induction media to enhance biomass and protein production.
    These methodological approaches should be applied systematically, with careful documentation of expression results under each condition to determine the optimal combination for your specific UPF0319 protein VP1 construct .

What purification strategies are most effective for isolating high-purity recombinant UPF0319 protein VP1?

A robust purification protocol for recombinant UPF0319 protein VP1 typically involves sequential chromatographic techniques:

  • Initial capture: Immobilized metal affinity chromatography (IMAC) using Ni-NTA or Co-NTA resins is highly effective for His-tagged UPF0319 protein constructs, allowing for specific binding under native or denaturing conditions.

  • Intermediate purification: Ion exchange chromatography can separate the target protein from contaminants with different charge properties. The selection between cation or anion exchange depends on the isoelectric point of your specific UPF0319 construct.

  • Polishing step: Size exclusion chromatography (SEC) provides final purification and allows assessment of protein homogeneity, aggregation state, and oligomerization.

  • Quality control assessment: Analytical techniques including SDS-PAGE, Western blotting, and mass spectrometry should be employed to verify protein identity, purity, and integrity.
    The specific buffer conditions, salt concentrations, and pH values should be optimized empirically for each step to maximize yield while maintaining protein stability and activity .

How can researchers effectively troubleshoot low expression or insolubility issues with UPF0319 protein VP1?

When encountering expression challenges with UPF0319 protein VP1, implement this systematic troubleshooting approach:

  • For low expression issues:

    • Verify expression vector sequence integrity

    • Evaluate mRNA stability using RT-PCR

    • Test different E. coli strains (BL21, Rosetta for rare codons)

    • Modify induction parameters (lower temperature, reduced IPTG)

    • Consider auto-induction media to avoid toxicity issues

  • For protein insolubility:

    • Reduce expression rate (lower temperature, weaker promoter)

    • Co-express with molecular chaperones (GroEL/ES, DnaK)

    • Test fusion partners (SUMO, MBP, Thioredoxin) known to enhance solubility

    • Optimize lysis conditions and buffer components

    • Evaluate refolding protocols from inclusion bodies if necessary
      Implementing a design of experiments (DOE) approach can efficiently identify optimal conditions by testing multiple variables simultaneously rather than varying one factor at a time .

What are the recommended approaches for characterizing the structural properties of purified UPF0319 protein VP1?

A comprehensive structural characterization of UPF0319 protein VP1 should incorporate multiple complementary techniques:

  • Secondary structure analysis:

    • Circular dichroism (CD) spectroscopy to determine α-helix, β-sheet, and random coil content

    • Fourier-transform infrared spectroscopy (FTIR) as a complementary method for secondary structure determination

  • Tertiary structure characterization:

    • X-ray crystallography for high-resolution structural determination (requires successful crystallization)

    • Nuclear magnetic resonance (NMR) spectroscopy for solution-state structural analysis (more suitable for smaller domains)

    • Cryo-electron microscopy for larger assemblies or complexes

  • Stability and conformational assessment:

    • Differential scanning calorimetry (DSC) to measure thermal stability

    • Intrinsic fluorescence spectroscopy to monitor tertiary structure changes

    • Limited proteolysis combined with mass spectrometry to identify domain boundaries and flexible regions

  • Quaternary structure analysis:

    • Size exclusion chromatography with multi-angle light scattering (SEC-MALS) for accurate molecular weight determination

    • Analytical ultracentrifugation to characterize oligomerization states and heterogeneity
      These methodologies provide complementary information about protein structure and should be selected based on available instrumentation and specific research questions .

How can researchers effectively assess the functional activity of recombinant UPF0319 protein VP1?

Since UPF0319 proteins are uncharacterized, functional assessment requires multiple approaches:

  • Binding partner identification:

    • Pull-down assays using the recombinant protein as bait

    • Yeast two-hybrid screening to identify potential protein-protein interactions

    • Co-immunoprecipitation studies with candidate interacting partners

    • Surface plasmon resonance (SPR) or bio-layer interferometry (BLI) for quantitative binding kinetics

  • Functional domain mapping:

    • Creation of truncation or deletion mutants to identify functional regions

    • Site-directed mutagenesis of conserved residues to assess their importance

    • Domain swapping experiments with related proteins

  • Cellular localization studies:

    • Immunofluorescence microscopy with tagged recombinant protein

    • Subcellular fractionation followed by Western blotting

    • Live-cell imaging with fluorescently labeled protein

  • Enzymatic activity screening:

    • General assays for nucleic acid binding, ATPase activity, or other common biochemical functions

    • Substrate specificity determination if enzymatic activity is identified
      These approaches should be conducted systematically to build a comprehensive understanding of the protein's function, starting with broader screening methods before proceeding to more targeted analyses .

How can structural biology approaches be applied to elucidate UPF0319 protein function through comparative analysis with Upf1p?

Despite limited sequence homology, structural biology approaches can potentially reveal functional relationships between UPF0319 and better-characterized proteins like Upf1p:

  • Structural homology modeling:

    • Generate computational models of UPF0319 protein using available protein structure prediction tools

    • Compare predicted structural features with known Upf1p domains

    • Identify potential conserved structural motifs despite sequence divergence

  • Structural alignment analysis:

    • Utilize tools like DALI or TM-align to compare experimental or predicted structures

    • Identify potential functional sites based on structural conservation

    • Map evolutionarily conserved residues onto structures to identify functional hotspots

  • Protein-protein interaction surface mapping:

    • Analyze the Upf1p interaction with nuclear pore proteins (Nup100p and Nup116p)

    • Search for similar interaction surfaces in UPF0319 protein

    • Test computationally predicted interactions experimentally

  • Domain function transfer experiments:

    • Create chimeric proteins swapping domains between UPF0319 and Upf1p

    • Assess functional complementation in appropriate assay systems

    • Identify minimal functional units through progressive domain exchange
      This integrative approach combines computational prediction with experimental validation to systematically explore potential functional relationships between these protein families .

What considerations are important when designing expression systems for structural studies of UPF0319 protein VP1?

For structural biology applications, specialized expression strategies are essential:

How can researchers develop targeted proteomic assays for quantifying UPF0319 protein VP1 in complex biological samples?

Development of sensitive and specific proteomic assays for UPF0319 protein VP1 requires:

  • Peptide selection strategy:

    • Identify proteotypic peptides unique to UPF0319 protein VP1

    • Select peptides with favorable ionization properties for mass spectrometry

    • Avoid regions prone to post-translational modifications or processing

    • Synthesize stable isotope-labeled standards of selected peptides

  • Multiple reaction monitoring (MRM) assay development:

    • Optimize collision energies for each target peptide

    • Determine retention time windows for scheduled MRM

    • Establish limits of detection and quantification

    • Validate assay specificity against complex matrix backgrounds

  • Sample preparation optimization:

    • Develop efficient extraction protocols for different sample types

    • Establish procedures to minimize protein degradation

    • Implement fractionation strategies for low-abundance targets

    • Optimize digestion conditions for complete and reproducible processing

  • Data analysis and validation approach:

    • Implement appropriate normalization strategies

    • Establish technical and biological variation parameters

    • Develop standard curves using recombinant protein standards

    • Validate results with orthogonal methods (Western blotting, ELISA)
      This methodological framework enables absolute quantification of UPF0319 protein VP1 across different experimental conditions and sample types, facilitating functional studies in complex biological systems .

How do UPF0319 proteins compare functionally with VP1 proteins found in viral systems like Porcine bocavirus?

Despite sharing "VP1" in their nomenclature, UPF0319 protein VP1 and viral capsid VP1 proteins (such as those in Porcine bocavirus) represent distinct protein families with fundamentally different functions:

  • Structural and functional differences:

    • Viral VP1 proteins function primarily as capsid components with defined structural roles in virus assembly and host cell recognition

    • UPF0319 proteins are cellular proteins of currently uncharacterized function

    • Sequence analysis reveals no significant homology between these protein families

  • Evolutionary relationship:

    • Viral VP1 proteins evolved specifically for viral structural requirements

    • UPF0319 proteins likely evolved within cellular contexts for non-viral functions

    • Any naming similarities are coincidental rather than indicative of functional relationships

  • Research methodologies:

    • Viral VP1 proteins are often studied in the context of viral assembly, immunogenicity, and host-cell interactions

    • UPF0319 proteins require unbiased functional genomics approaches to elucidate their roles

    • Different experimental systems are typically employed for these distinct protein families
      Understanding these fundamental differences is crucial when reviewing literature, as search results may include information about both protein families despite their distinct biological contexts and functions .

What can comparative genomics reveal about UPF0319 protein conservation and potential function?

Comparative genomics approaches provide valuable insights into UPF0319 protein evolution and function:

  • Phylogenetic distribution analysis:

    • Map the presence/absence of UPF0319 across diverse species

    • Identify patterns of co-evolution with other gene families

    • Determine if horizontal gene transfer events have occurred

  • Sequence conservation mapping:

    • Identify highly conserved motifs across diverse species

    • Map conservation onto structural models to identify functional sites

    • Compare conservation patterns with related protein families

  • Genomic context analysis:

    • Examine operon structures in prokaryotes containing UPF0319 genes

    • Analyze promoter elements and regulatory sequences

    • Identify consistently co-regulated genes across species

  • Methodological framework for functional prediction:

    • Implement gene neighborhood analysis

    • Utilize protein-protein interaction network integration

    • Apply gene expression correlation analysis

    • Perform phenotypic profiling of knockout/knockdown organisms
      These approaches can generate testable hypotheses about UPF0319 protein function based on evolutionary relationships and genomic context, guiding experimental design for functional characterization studies .

What are the potential applications of UPF0319 protein VP1 in developing protein-based diagnostic tools similar to the VP1-based ELISA for Porcine bocavirus?

While UPF0319 proteins and viral VP1 proteins serve distinct biological functions, the methodological approaches used for developing the VP1-based ELISA for Porcine bocavirus can inform similar applications for UPF0319 proteins:

  • Peptide epitope identification strategy:

    • Analyze UPF0319 protein sequences for regions with high antigenicity

    • Design synthetic peptides representing conserved regions with predicted surface exposure

    • Validate peptide immunogenicity in appropriate animal models

  • Assay development methodology:

    • Optimize coating conditions for recombinant protein or synthetic peptides

    • Establish appropriate blocking conditions to minimize background

    • Determine optimal sample dilutions and incubation parameters

    • Validate specificity against related protein families

  • Performance optimization approach:

    • Implement checkerboard titration to determine optimal reagent concentrations

    • Establish reproducibility parameters through intra- and inter-assay variation analysis

    • Determine sensitivity limits using purified recombinant protein standards

    • Validate against diverse sample matrices

  • Limitations and considerations:

    • Recognize that biological relevance depends on establishing UPF0319 protein connection to disease or physiological states

    • Address potential cross-reactivity with structural homologs

    • Establish appropriate reference standards for quantification
      These methodological frameworks can be applied to develop sensitive and specific assays for UPF0319 proteins once their biological significance is better established through basic research .

How can CRISPR-Cas9 gene editing be leveraged to investigate UPF0319 protein function in cellular models?

CRISPR-Cas9 technology offers powerful approaches for UPF0319 functional characterization:

  • Knockout strategy design:

    • Generate complete gene deletions to assess loss-of-function phenotypes

    • Create conditional knockout systems for essential genes

    • Implement tissue-specific or inducible knockout approaches in complex organisms

    • Design appropriate controls including rescue experiments with recombinant protein

  • Protein tagging methodology:

    • Create endogenous C- or N-terminal tags for localization studies

    • Implement split-GFP or HaloTag systems for dynamic protein interaction studies

    • Design epitope tags for chromatin immunoprecipitation if DNA-binding functions are suspected

    • Validate tag impact on protein function through complementation assays

  • Domain function analysis:

    • Generate precise deletions of predicted functional domains

    • Create point mutations in conserved residues

    • Implement base editing for specific amino acid substitutions

    • Design domain swaps to test functional hypotheses

  • High-throughput screening approaches:

    • Develop CRISPR activation (CRISPRa) or interference (CRISPRi) libraries

    • Implement pooled screenings with phenotypic selection

    • Design synthetic genetic interaction screens

    • Establish appropriate readout systems for phenotypic assessment
      These genetic engineering approaches provide powerful tools to systematically investigate UPF0319 protein function in relevant cellular contexts, complementing biochemical studies with recombinant proteins .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.